Abstract: A method for treating an inflammatory condition in a mammalian patient by administering an effective amount of a 1-aralkyl-3-amino-2-pyrazoline compound having the formula ##STR1## or a pharmaceutically acceptable acid addition salt thereof, wherein: m and n are integers ranging from 0 to 6,R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5, which can be the same or different, are hydrogen or lower alkyl,X.sub.1, X.sub.2, X.sub.3, X.sub.4, and X.sub.5, which can be the same or different, are hydrogen, halogen, alkyl, cycloalkyl, alkoxy, alkanoyloxy, phenyl, phenoxy, benzyloxy, haloalkyl, mercaptoalkyl, amino, alkylamine, hydroxyl, nitro, and nitrile,each of X.sub.1 -X.sub.5, when they contain carbon, having not more than 6 carbon atoms.The compounds used in the method have unexpectedly low toxicity.